With its dual benefits of glucose regulation and weight loss, semaglutide represents a powerful tool in the fight against obesity and diabetes
It plays an important role in regulating meal patterns, so that its absence impairs the ability to terminate meals
Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation, which typically diminish over time
And it noted that "a review of the available data has not established that semaglutide causes NAION, only a potential link between the two." Novo Nordisk did not comment directly on Engels individual lawsuit when asked for comment
Kosheleva L, Koshelev D, Lagunas-Rangel FA, Levit S, Rabinovitch A, Schith HB
Panels a - b : LSM changes from baseline at Week 48 in leptin and adiponectin are based on a MMRM using log-transformation for the efficacy estimand